Skip to main content
56th ASAM Annual Conference Main banner
Final Program


Preview Program
Back

Focus Session

Concurrent Sessions #4

Cannabinoids and Pregnancy: ASAM Members, Patients and the Public - A Vital Discourse/Debate

Friday, April 25, 2025
3:00 PM – 4:15 PM  
CANNABIS, CANNABINOIDS AND PREGNANCY:
ASAM PHYSICIANS, PATIENTS AND THE PUBLIC - A VITAL DISCOURSE AND DEBATE

Interactive, Stimulating and Powerful Focus Session
Stephen M. Taylor MD President-Elect ASAM, Panelist Commentator
GBunt MD ASAM Cannabis and Pregnancy Special Interest Group Chair

Sheryl Ryan, MD, Stellar ASAM Pediatrician
Katrina Mark, MD, Stellar ASAM Obstetrician/Gynecologist
DISCOURSE and DEBATE
CANNABIS/THC/CBD during PREGNANCY and BREASTFEEDING
Clinical/Advocacy/Policy

With Vigorous and Informative Interactive Discussion with Participants

Learning Objectives:

Learners will be able to:
  • Participants will be fully informed of the most current scientific clinical data regarding the adverse effects of cannabis and cannabinoid use during pregnancy and breastfeeding
  • Participants will be fully informed of the most current clinical and advocacy Issues and controversies regarding cannabis use during pregnancy and breastfeeding
  • Participants will be fully informed of the most current and diverse viewpoints among ASAM colleagues regarding clinical, advocacy and policy issues of cannabis use during pregnancy and breastfeeding
Disclosure(s):
Gregory c. Bunt, MD FASAM DFISAM: No financial relationships to disclose
Stephen M. Taylor, MD, MPH, DFAPA, DFASAM: No financial relationships to disclose
Katrina Mark, MD, FACOG, FASAM: No financial relationships to disclose
Sheryl A. Ryan, MD, FASAM, FAAP: Best Doctors of America: I provide clinical review of cases requesting a second opinion and provide clinical assessment in writing to organization. (Ongoing)